Navigation Links
Crusade Against Cancer: Collaborations On The Anvil

The IBM Corp., based in Armonk, N.Y., announced this Tuesday its decision to join forces with three research centers, as part of an overall effort to help accelerate cancer research, diagnosis and treatment//.

IBM will collaborate with the Memorial Sloan-Kettering Cancer Center, the Molecular Profiling Institute and the CHU Sainte-Justine Research Center under separate agreements.

IBM and Memorial Sloan-Kettering Cancer Center (MSKCC) will erect a state-of-the-art integrated information management system to improve the ability of clinicians and researchers to study long-term cancer-related illnesses, identify disease trends and determine success rates.

Funded by a $3 million grant of technology and services from IBM, MSKCC will include a comprehensive system to integrate its hospital data with text mining and related analytical capabilities into a unified information management environment to facilitate predictive analysis and research.

In addition, pathologists at MSKCC are working closely with researchers at IBM to create a searchable database for pathology reports.

"This is an excellent multi-sector model that can drive integration of molecular medicine into areas where it's truly needed, including cancer detection, treatment, and ultimately prevention," said Dr Anna Barker, deputy director of the National Cancer Institute (NCI). "The convergence of advanced technologies and post-genomics science will change cancer medicine in ways we cannot yet envision."

In a separate collaboration, cancer experts at three Manchester institutions have decided to work together at a new "world class" research center in the city. Researchers at Christie Hospital, the Paterson Institute and the University of Manchester will pool their efforts to find more effective treatments.

Their medical research will be coordinated by the newly-formed Manchester Cancer Research Center and it is hoped the center will come up with major breakthroughs within five years.

The hub of the MCRC will be at Christie Hospital with researchers from the University's Faculty of Life Sciences and the Faculty of Medical and Human Sciences contributing their expertise.

Under a five-year plan for the center, it is expected that funding will double from £30m to £60m and that the workforce will increase from 350 to 700.

It is hoped the new center will allow chemists and biologists to work closely with doctors at Christie to take advances from the lab straight on to the hospital ward. Professor Nic Jones, director of the Paterson Institute, who will become director of the MCRC, said: "In the short term we will become a centre of research excellence, with better clinicians. We'll develop new therapies, and patients do better when they are on clinical trails." "The science has reached a critical stage now. We understand cancers so much more that now we need to start bigger and better trials on patients. I would expect to see some significant breakthroughs in the next five years."
'"/>




Related medicine news :

1. Organ Donation Crusader Passes Away
2. Crusade Against Malnutrition
3. Tuberculosis, A Challenge To The Political Will Of Governments, Says Veteran Crusader
4. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
5. Diabetics Need to Guard Against Nail Fungus
6. New Weapon Against Germs
7. Estrogen Found To Protect the Colon Against Cancer
8. Diet Found To Offer Protection Against Leukemia
9. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
10. WHO Issues Caution Against Bird Flu Epidemic
11. New Supplement Found To Be Effective Against Sunburn
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: